Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar Lines

NCT01271452 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT01271452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01271452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar Lines
Lead sponsor
Allergan
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2010
Completion date
April 30, 2011
Enrollment
224 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glabellar lines